In the present study, the number of U87 cells expressing GFAP, β-tubulin III and Galc was significantly increased following the administration of ATRA, confirming the potent differentiation-inducing ability of ATRA in malignant glioma cells. The gene discussed is GALC; the disease is malignant glioma.